ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,587.00
0.23%
S&P ASX All Technology
2,972.40
0.12%
Brent Oil
84.24
0.84%
US Dollar vs AUD
1.53151
0.03%
Bitcoin
58,845.90
1.06%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Compugen Ltd (CGEN)

  7. Compugen Ltd (CGEN) News

CGEN Compugen Ltd

1.99
0.00 (0.00%)
Pre Market
Last Updated: 21:59:19
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Compugen Ltd CGEN NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.00 0.00% 1.99 21:59:19
Open Price Low Price High Price Close Price Previous Close
1.99
more quote information »

Recent News

Date Time Source Heading
25/4/202421:00PRNUSCompugen to Present New Clinical Data Showing COM701 Triple..
10/4/202421:00PRNUSCompugen Publishes Paper in Cancer Immunology Research..
03/4/202422:00PRNUSCompugen to Participate in Two Upcoming Investor Conferences
11/3/202422:00PRNUSCompugen Selected for two Oral Presentations at the Keystone..
06/3/202423:00PRNUSCompugen to Present Data Reflecting its Diversified..
06/3/202408:06EDGAR2Form 20-F - Annual and transition report of foreign private..
05/3/202423:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/3/202423:00PRNUSCompugen Reports Fourth Quarter and Full Year 2023 Results
05/3/202422:05IHMARKETNEWSU.S. Futures Dip, Crude Oil Fluctuates
26/2/202423:00PRNUSCompugen to Present at the Leerink Partners Global Biopharma..
20/2/202423:00PRNUSCompugen to Release Fourth Quarter and Full Year 2023..
15/2/202423:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/2/202423:00PRNUSCompugen Announces Appointment of Michelle Mahler M.D. as..
08/1/202423:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/1/202423:05PRNUSCompugen to Receive $10 Million Milestone Payment Following..
08/1/202423:00PRNUSCompugen Regains Compliance with Nasdaq Minimum Bid Price..
20/12/202301:30APSStrong Open For Biotech Following Exclusive Agreement..
19/12/202323:12EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19/12/202323:10PRNUSCompugen will be Eligible to Receive $10 Million Milestone..
19/12/202323:05PRNUSCompugen to Host Conference Call to Discuss Exclusive..
19/12/202323:00BWGilead and Compugen Announce Exclusive License Agreement for..
07/11/202323:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/11/202323:00PRNUSCompugen Reports Third Quarter 2023 Results
06/11/202323:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/11/202323:00PRNUSCompugen's COM701 (anti-PVRIG) Mediates Anti-Tumor Activity..
04/11/202307:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/11/202307:35PRNUSCompugen Announces Receipt of Nasdaq Minimum Bid Price..
01/11/202300:00PRNUSCompugen to Present New Data at SITC 2023 Suggesting Leading..
24/10/202322:00PRNUSCompugen to Release Third Quarter 2023 Results on Tuesday,..
03/10/202322:00PRNUSCompugen to Present at Single Cell Genomics 2023 Meeting
02/10/202322:00PRNUSCompugen Expands Intellectual Property with New Japanese..
27/9/202323:00PRNUSCompugen to Present New Clinical and Pre-Clinical Data in..
21/9/202321:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/8/202321:00PRNUSCompugen to Present at the H.C. Wainwright 25th Annual..
23/8/202322:00EDGAR2Form 20-F/A - Annual and transition report of foreign..
07/8/202322:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/8/202321:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/8/202321:00PRNUSCompugen Reports Second Quarter 2023 Results
24/7/202321:00PRNUSCompugen to Release Second Quarter 2023 Results on Monday,..
17/7/202321:00PRNUSCompugen Wins on PVRIG European Patent Opposition Pursued by..
22/6/202321:00PRNUSCompugen Doses First Patient in Triple Immunotherapy..
13/6/202321:00PRNUSCompugen Regains Compliance with Nasdaq Minimum Bid Price..
05/6/202321:00PRNUSCompugen's COM701 (anti-PVRIG) Demonstrates Preliminary..
15/5/202321:00PRNUSCompugen Reports First Quarter 2023 Results
11/5/202321:00PRNUSCompugen to Host DNAM-1 Axis Virtual Investor Event with KOL..
09/5/202321:00PRNUSCompugen to Present at the JMP Securities Life Sciences..

Your Recent History

NASDAQ
CGEN
Compugen
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved